Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The category "Immune and Central Nervous System Cells" encompasses a spectrum of **immune cell types present within the CNS**, including microglia (the primary innate immune cells of the brain), astrocytes, oligodendrocytes, meningeal macrophages, perivascular macrophages, as well as infiltrating lymphocytes such as T and B cells[1][3][5][6]. These cells play varied roles in CNS homeostasis, immune surveillance, inflammatory responses, synaptic modulation, and neurodevelopment. Dysfunction or dysregulation of CNS immune cells is involved in the pathogenesis of a broad range of neurological diseases including multiple sclerosis, neurodegenerative disorders (e.g., Alzheimer's, Parkinson's), CNS infections, and CNS tumors[2][3][7]. Because this group is heterogeneous and not a single molecular entity, it is not an appropriate target designation for pharmacological intervention.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immune and Central Nervous System Cells.